Fig. 3From: Evidence for benefit of statins to modify cognitive decline and risk in Alzheimer’s diseaseContinual use of statins vs placebo. a ADAS-cog scores at baseline. b Continual use of different statins vs no statin use. *Significant differences between statin users and nonusers (p < 0.05). ADAS-cog Alzheimer’s Disease Assessment Scale—cognitive subscaleBack to article page